Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome

Nano Research

Volumn 8, Issue 2, 2015, Pages 621-635

  Liu, Shengyan ^a,b   Chang, Chu Ning ^a   Verma, Mohit S ^a,b   Hileeto, Denise ^a   Muntz, Alex ^a   Stahl, Ulrike ^a   Woods, Jill ^a   Jones, Lyndon W ^a,b   Gu, Frank X ^a,b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

biocompatibility; copolymer; drug delivery; mucoadhesion; nanoparticle; ophthalmology

Indexed keywords

EID: 84923323848     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-014-0547-3     Document Type: Article

References (62)

1. Gaudana, R.; Jwala, J.; Boddu, S. H. S.; Mitra, A. K. Recent perspectives in ocular drug delivery. Pharm. Res.2009, 26, 1197–1216.
2. Diebold, Y.; Calonge, M. Applications of nanoparticles in ophthalmology. Prog. Retin. Eye Res.2010, 29, 596–609.
3. Liu, S.; Jones, L.; Gu, F. X. Nanomaterials for ocular drug delivery. Macromol. Biosci.2012, 12, 608–620.
4. Cho, H. K.; Cheong, I. W.; Lee, J. M.; Kim, J. H. Polymeric nanoparticles, micelles and polymersomes from amphiphilic block copolymer. Korean. J. Chem. Eng.2010, 27, 731–740.
5. Subbiah, R.; Veerapandian, M.; Yun, K. S. Nanoparticles: Functionalization and multifunctional applications in biomedical sciences. Curr. Med. Chem.2010, 17, 4559–4577.
6. Gavini, E.; Chetoni, P.; Cossu, M.; Alvarez, M. G.; Saettone, M. F.; Giunchedi, P. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: In vitro/in vivo studies. Eur. J. Pharm. Biopharm.2004, 57, 207–212.
7. Yoncheva, K.; Vandervoort, J.; Ludwig, A. Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application. Pharm. Dev. Technol.2011, 16, 29–35.
8. Gupta, H.; Aqil, M.; Khar, R. K.; Ali, A.; Bhatnagar, A.; Mittal, G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomed-nanotechnol.2010, 6, 324–333.
9. Lee, V. H. L. Review: New directions in the optimization of ocular drug delivery. J. Ocul. Pharmacol.1990, 6, 157–164.
10. Zimmer, A.; Kreuter, J. Microspheres and nanoparticles used in ocular delivery systems. Adv. Drug Deliv. Rev.1995, 16, 61–73.
11. Bazile, D.; Prud□homme, C.; Bassoullet, M. T.; Marlard, M.; Spenlehauer, G.; Veillard, M. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci.1995, 84, 493–498.
12. Dhar, S.; Gu, F. X.; Langer, R.; Farokhzad, O. C.; Lippard, S. J. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc. Natl. Acad. Sci. U.S.A.2008, 105, 17356–17361.
13. Dong, Y. and Feng, S.-S. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy. Biomaterials2007, 28, 4154–4160.
14. Esmaeili, F.; Ghahremani, M. H.; Ostad, S. N.; Atyabi, F.; Seyedabadi, M.; Malekshahi, M. R.; Amini, M.; Dinarvand, R. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate. J. Drug Target.2008, 16, 415–423.
15. Gao, Y.; Sun, Y.; Ren, F.; Gao, S. PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate. Drug Dev. Ind. Pharm.2010, 36, 1131–1138.
16. Vega, E.; Egea, M. A.; Calpena, A. C.; Espina, M.; Garcia, M. L. Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery. Int. J. Nanomedicine2012, 7, 1357–1371.
17. Yang, J.; Yan, J.; Zhou, Z.; Amsden, B. G. Dithiol-PEG-PDLLA micelles: Preparation and evaluation as potential topical ocular delivery vehicle. Biomacromolecules2014, 15, 1346–1354
18. Verma, M. S.; Liu, S.; Chen, Y. Y.; Meerasa, A.; Gu, F. X. Size-tunable nanoparticles composed of Dextran-b-poly(d,l-lactide) for drug delivery applications. Nano. Res.2012, 5, 49–61.
19. Goodwin, A. P.; Tabakman, S. M.; Welsher, K.; Sherlock, S. P.; Prencipe, G.; Dai, H. Phospholipid-Dextran with a single coupling point: A useful amphiphile for functionalization of nanomaterials. J. Am. Chem. Soc.2009, 131, 289–296.
20. Ludwig, A. The use of mucoadhesive polymers in ocular drug delivery. Adv. Drug Deliv. Rev.2005, 57, 1595–1639.
21. Shaikh, R.; Raj Singh, T. R.; Garland, M. J.; Woolfson, A. D.; Donnelly, R. F. Mucoadhesive drug delivery systems. J. Pharm. Bioall.2011, 3, 89–100.
22. Khutoryanskiy, V. V. Advances in mucoadhesion and mucoadhesive polymers. Macromol. Biosci.2011, 11, 748–764.
23. du Toit, L. C.; Pillay, V.; Choonara, Y. E.; Govender, T.; Carmichael, T. Ocular drug delivery-A look towards nanobioadhesives. Expert Opin. Drug Deliv.2011, 8, 71–94.
24. Li, N.; Zhuang, C.; Wang, M.; Sui, C.; Pan, W. Low molecular weight chitosan-coated liposomes for ocular drug delivery: In vitro and in vivo studies. Drug Deliv.2012, 19, 28–35.
25. Mahmoud, A. A.; El-Feky, G. S.; Kamel, R.; Awad, G. E. A. Chitosan/sulfobutylether-beta-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int. J. Pharm.2011, 413, 229–236.
26. Abdelbary, G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm. Dev. Technol.2011, 8, 44–56.
27. Li, N.; Zhuang, C.; Wang, M.; Sun, X.; Nie, S.; Pan, W. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int. J. Pharm.2009, 379, 131–138.
28. De Campos, A. M.; Sanchez, A.; Alonso, M. J. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm.2001, 224, 159–168.
29. Matsumoto, A.; Cabral, H.; Sato, N.; Kataoka, K.; Miyahara, Y. Assessment of tumor metastasis by the direct determination of cell-membrane sialic acid expression. Angew. Chem. Int. Edit.2010, 49, 5494–5497.
30. Matsumoto, A.; Sato, N.; Cabral, H.; Kataoka, K.; Miyahara, Y. Self-assembled molecular gate field effect transistor for label free sialic acid detection at cell membrane. Eurosensor XXIV Conference2010, 5, 926–929.
31. Matsumoto, A.; Sato, N.; Kataoka, K.; Miyahara, Y. Noninvasive sialic acid detection at cell membrane by using phenylboronic acid modified self-assembled monolayer gold electrode. J. Am. Chem. Soc.2009, 131, 12022–12023.
32. Ivanov, A. E.; Eccles, J.; Panahi, H. A.; Kumar, A.; Kuzimenkova, M. V.; Nilsson, L.; Bergenstahl, B.; Long, N.; Phillips, G. J.; Mikhalovsky, S. V.; et al. Boronate-containing polymer brushes: Characterization, interaction with saccharides and mammalian cancer cells. J. Biomed. Mater. Res. A.2009, 88A, 213–225.
33. Liu, A.; Peng, S.; Soo, J. C.; Kuang, M.; Chen, P.; Duan, H. Quantum dots with phenylboronic acid tags for specific labeling of sialic acids on living cells. Anal. Chem.2011, 83, 1124–1130.
34. Otsuka, H.; Uchimura, E.; Koshino, H.; Okano, T.; Kataoka, K. Anomalous binding profile of phenylboronic acid with N-acetylneuraminic acid (Neu5Ac) in aqueous solution with varying pH. J. Am. Chem. Soc.2003, 125, 3493–3502.
35. Cheng, C.; Zhang, X.; Wang, Y.; Sun, L.; Li, C. Phenylboronic acid-containing block copolymers: Synthesis, self-assembly, and application for intracellular delivery of proteins. New J. Chem.2012, 36, 1413–1421.
36. Deshayes, S.; Cabral, H.; Ishii, T.; Miura, Y.; Kobayashi, S.; Yamashita, T.; Matsumoto, A.; Miyahara, Y.; Nishiyama, N.; Kataoka, K. Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors. J. Am. Chem. Soc.2013, 135, 15501–15507.
37. Liu, S.; Jones, L.; Gu, F. X. Development of mucoadhesive drug delivery system using phenylboronic acid functionalized poly(d,l-lactide)-b-Dextran nanoparticles. Macromol. Biosci.2012, 12, 1622–1626.
38. Shen, J.; Wang, Y.; Ping, Q.; Xiao, Y.; Huang, X. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J. Controlled Release2009, 137, 217–223.
39. Vijay, A. K.; Sankaridurg, P.; Zhu, H.; Willcox, M. D. P. Guinea pig models of acute keratitis responses. Cornea2009, 28, 1153–1159.
40. Cole, N.; Hume, E. B. H.; Vijay, A. K.; Sankaridurg, P.; Kumar, N.; Willcox, M. D. P. In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU. Invest. Ophthalmol. Vis. Sci.2010, 5, 390–395.
41. Diebold, Y.; Jarrin, M.; Saez, V.; Carvalho, E. L. S.; Orea, M.; Calonge, M.; Seijo, B.; Alonso, M. J. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials2007, 28, 1553–1564.
42. Dursun, D.; Wang, M.; Monroy, D.; Li, D. Q.; Lokeshwar, B. L.; Stern, M. E.; Pflugfelder, S. C. A mouse model of keratoconjunctivitis sicca. Invest. Ophthalmol. Vis. Sci.2002, 43, 632–638.
43. Bromba, C.; Carrie, P.; Chui, J. K. W.; Fyles, T. M. Phenyl boronic acid complexes of diols and hydroxyacids. Supramol. Chem.2009, 21, 81–88.
44. Shiomori, K.; Ivanov, A. E.; Galaev, I. Y.; Kawano, Y.; Mattiasson, B. Thermoresponsive properties of sugar sensitive copolymer of N-isopropylacrylamide and 3-(acrylamido)phenylboronic acid. Macromol. Chem. Physic.2004, 205, 27–34.
45. Kitano, S.; Kataoka, K.; Koyama, Y.; Okano, T.; Sakurai, Y. Glucose-responsive complex-formation between poly(vinyl alcohol) and poly(n-vinyl-2-pyrrolidone) with pendent phenylboronic acid moieties. Makromol. Chem-Rapid.1991, 12, 227–233.
46. Wang, Y.; Zhang, X.; Han, Y.; Cheng, C.; Li, C. pH- and glucose-sensitive glycopolymer nanoparticles based on phenylboronic acid for triggered release of insulin. Carbohydr. Polym.2012, 89, 124–131.
47. Lee, D.; Shirley, S. A.; Lockey, R. F.; Mohapatra, S. S. Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Resp. Res.2006, 7, 112.
48. Yuan, X.-B.; Li, H.; Yuan, Y. Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohydr. Polym.2006, 65, 337–345.
49. Hermans, K.; Van Den Plas, D.; Schreurs, E.; Weyenberg, W.; Ludwig, A. Cytotoxicity and anti-inflammatory activity of Cyclosporine A loaded PLGA nanoparticles for ocular use. Pharmazie2014, 69, 32–37.
50. Shen, J.; Deng, Y.; Jin, X.; Ping, Q.; Su, Z.; Li, L. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for Cyclosporine A: Improving in vivo ocular distribution. Int. J. Pharm.2010, 402, 248–253.
51. Aksungur, P.; Demirbilek, M.; Denkbas, E. B.; Vandervoort, J.; Ludwig, A.; Unlu, N. Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies. J. Controlled Release2011, 151, 286–294.
52. Basaran, E.; Yenilmez, E.; Berkman, M. S.; Buyukkoroglu, G.; Yazan, Y. Chitosan nanoparticles for ocular delivery of Cyclosporine A. J. Microencapsul.2014, 31, 49–57.
53. Dong, Y. C.; Feng, S. S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials2004, 25, 2843–2849.
54. Musumeci, T.; Ventura, C. A.; Giannone, I.; Ruozi, B.; Montenegro, L.; Pignatello, R.; Puglisi, G. PLA/PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm.2006, 325, 172–179.
55. Francis, M. F.; Lavoie, L.; Winnik, F. M.; Leroux, J.-C. Solubilization of cyclosporin A in Dextran-g-polyethyleneglycolalkyl ether polymeric micelles. Eur. J. Pharm. Biopharm.2003, 56, 337–346.
56. Aliabadi, H. M.; Mahmud, A.; Sharifabadi, A. D.; Lavasanifar, A. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of Cyclosporine A. J. Controlled Release2005, 104, 301–311.
57. Velluto, D.; Demurtas, D.; Hubbell, J. A. PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: Cyclosporin A as an example. Mol. Pharm.2008, 5, 632–642.
58. Mondon, K.; Zeisser-Labouebe, M.; Gurny, R.; Moeller, M. Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: A suitability study. Eur. J. Pharm. Biopharm.2011, 77, 56–65.
59. Yang, W. Q.; Gao, X. M.; Wang, B. H. Boronic acid compounds as potential pharmaceutical agents. Med. Res. Rev.2003, 23, 346–368.
60. Toshida, H.; Nakayasu, K.; Kanai, A. Effect of cyclosporin A eyedrops on tear secretion in rabbit. Jpn. J. Ophthalmol.1998, 42, 168–173.
61. Stern, M. E.; Gao, J. P.; Siemasko, K. F.; Beuerman, R. W.; Pflugfelder, S. C. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp. Eye Res.2004, 78, 409–416.
62. Keklikci, U.; Soker, S. I.; Sakalar, Y. B.; Unlu, K.; Ozekinci, S.; Tunik, S. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children. Jpn. J. Ophthalmol.2008, 52, 357–362.